JP2012518646A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518646A5
JP2012518646A5 JP2011551250A JP2011551250A JP2012518646A5 JP 2012518646 A5 JP2012518646 A5 JP 2012518646A5 JP 2011551250 A JP2011551250 A JP 2011551250A JP 2011551250 A JP2011551250 A JP 2011551250A JP 2012518646 A5 JP2012518646 A5 JP 2012518646A5
Authority
JP
Japan
Prior art keywords
blastomere
stem cells
drug according
cells
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551250A
Other languages
English (en)
Japanese (ja)
Other versions
JP5809068B2 (ja
JP2012518646A (ja
Filing date
Publication date
Priority claimed from US12/391,581 external-priority patent/US8563307B2/en
Application filed filed Critical
Publication of JP2012518646A publication Critical patent/JP2012518646A/ja
Publication of JP2012518646A5 publication Critical patent/JP2012518646A5/ja
Application granted granted Critical
Publication of JP5809068B2 publication Critical patent/JP5809068B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011551250A 2009-02-24 2010-02-19 免疫抑制−関連疾患の治療 Expired - Fee Related JP5809068B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/391,581 2009-02-24
US12/391,581 US8563307B2 (en) 2009-02-24 2009-02-24 Treatment of immunosuppression-related disorders
PCT/US2010/024735 WO2010099044A2 (en) 2009-02-24 2010-02-19 Treatment of immunosuppression-related disorders

Publications (3)

Publication Number Publication Date
JP2012518646A JP2012518646A (ja) 2012-08-16
JP2012518646A5 true JP2012518646A5 (enExample) 2012-11-29
JP5809068B2 JP5809068B2 (ja) 2015-11-10

Family

ID=42631141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011551250A Expired - Fee Related JP5809068B2 (ja) 2009-02-24 2010-02-19 免疫抑制−関連疾患の治療

Country Status (7)

Country Link
US (2) US8563307B2 (enExample)
EP (1) EP2400971B1 (enExample)
JP (1) JP5809068B2 (enExample)
CN (1) CN102325537B (enExample)
ES (1) ES2582582T3 (enExample)
TW (1) TWI496888B (enExample)
WO (1) WO2010099044A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
US8741642B2 (en) 2010-10-22 2014-06-03 Virginia Commonwealth University Methods for producing autologous immune cells resistant to myeloid-derived suppressor cells effects
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
WO2013176785A1 (en) * 2012-05-21 2013-11-28 The Trustees Of Columbia University In The City Of New York Trefoil family factor and uses thereof
TWI687519B (zh) 2012-12-06 2020-03-11 美商幹細胞生物科技股份有限公司 Lgr5+體幹細胞
EP2746769A1 (en) * 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
US9212225B1 (en) 2014-07-01 2015-12-15 Amphivena Therapeutics, Inc. Bispecific CD33 and CD3 binding proteins
KR102537102B1 (ko) 2015-05-29 2023-05-25 엠피베나 테라퓨틱스, 인크. 이중특이적 cd33 및 cd3 결합 단백질을 사용하는 방법

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2936171B2 (ja) 1989-09-01 1999-08-23 東ソー株式会社 血清アルブミンの製造方法
US6004807A (en) 1992-03-30 1999-12-21 Schering Corporation In vitro generation of human dendritic cells
US6916654B1 (en) * 1992-06-29 2005-07-12 Oklahoma Medical Research Foundation Universal donor cells
WO1998042838A1 (en) * 1997-03-25 1998-10-01 Morphogenesis, Inc. Universal stem cells
AU1705599A (en) 1997-11-26 1999-06-15 Allegheny University Of The Health Sciences Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
WO1999050392A1 (en) 1998-03-31 1999-10-07 Geron Corporation Methods and compositions for eliciting an immune response to a telomerase antigen
US6080399A (en) 1998-04-23 2000-06-27 Arch Development Corporation Vaccine adjuvants for immunotherapy of melanoma
JP3553858B2 (ja) 1999-08-25 2004-08-11 東洋紡績株式会社 血管網類似構造体を有する細胞培養用モジュール
US20030161817A1 (en) 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US7575921B2 (en) 1999-12-30 2009-08-18 Vbi Technologies, L.L.C. Spore-like cells and uses thereof
WO2002057428A1 (en) 2000-10-30 2002-07-25 University Of Massachusetts Isolation of spore-like cells from tissues exposed to extreme conditions
JP3977136B2 (ja) 2001-05-22 2007-09-19 キヤノン株式会社 コイルユニット
US7316932B2 (en) 2001-10-01 2008-01-08 Stemcell Technologies Inc. Method for separating cells
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
CA2478288A1 (en) 2002-03-07 2003-09-12 Adrian Woolfson Scd fingerprints
EP1509244B1 (en) 2002-06-06 2011-07-27 Immunicum AB New method and composition for producing a cellular allogeneic vaccine
AU2003287429A1 (en) * 2002-11-01 2004-06-07 Five Prime Therapeutics, Inc. Stem cell libraries
WO2004044158A2 (en) * 2002-11-08 2004-05-27 The Johns Hopkins University Human embryonic stem cell cultures, and compositions and methods for growing same
US20050003533A1 (en) 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
US20090004661A1 (en) 2003-05-26 2009-01-01 Reliance Life Sciences Pvt Ltd. Method of growing mesenchymal stem cells from bone marrow
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
EP1639097B1 (en) * 2003-06-25 2013-08-07 Ottawa Health Research Institute Methods and compositions for modulating stem cell growth and differentiation
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
ATE510006T1 (de) * 2004-09-03 2011-06-15 Moraga Biotechnology Inc Blastomerenähnliche, nichtembryonale, totipotente stammzellen und methoden zur gewinnung und anwendung
EP2410043A3 (en) 2004-12-29 2013-01-23 Hadasit Medical Research Services And Development Ltd. Stem cells culture systems
US8846395B2 (en) 2005-06-01 2014-09-30 Wisconsin Alumni Research Foundation Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+progenitors
BRPI0612672B8 (pt) 2005-06-24 2021-05-25 Cerule Llc composição de extrato aquoso de alga verde-azulada
US8476070B2 (en) 2005-08-29 2013-07-02 Technion Research & Development Foundation Limited Media for culturing stem cells
WO2009059032A2 (en) 2007-10-30 2009-05-07 University Of Louisville Research Foundation, Inc. Uses and isolation of very small embryonic-like (vsel) stem cells
US20080305079A1 (en) * 2006-01-06 2008-12-11 Mount Sinai School Of Medicine Of New York University Myeloid Suppressor Cells, Methods For Preparing Them, and Methods For Using Them For Treating Autoimmunity
US7939057B2 (en) 2006-01-25 2011-05-10 Mount Sinai School Of Medicine Methods and compositions for modulating the mobilization of stem cells
US9617515B2 (en) 2006-02-27 2017-04-11 Moraga Biotechnology Corporation Non-embryonic totipotent blastomere-like stem cells and methods therefor
HRP20160801T1 (hr) 2006-06-27 2016-08-12 Nutratec S.R.L. Ekstrakt aphanizomenon flos aquae (afa klamath), aktivne tvari i njihova uporaba
EP1894941A1 (en) * 2006-09-01 2008-03-05 Institut Pasteur Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens
US8759090B2 (en) * 2006-10-30 2014-06-24 University Of Central Florida Research Foundation, Inc. Stem cell banking system
US20090104160A1 (en) 2007-02-01 2009-04-23 Moraga Biotechnology Corporation Mobilization of Stem Cells After Trauma and Methods Therefor
WO2008148105A1 (en) 2007-05-25 2008-12-04 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
SI2173379T1 (sl) 2007-07-02 2015-12-31 Oncomed Pharmaceuticals, Inc. Sestavki in postopki za zdravljenje in diagnosticiranje raka
EP2676678A1 (en) 2007-07-17 2013-12-25 The General Hospital Corporation Methods to identify and enrich populations of ovarian cancer stem cells and somatic stem cells and uses thereof
WO2009061024A1 (en) 2007-11-09 2009-05-14 Rnl Bio Co., Ltd Method for isolating and culturing adult stem cells derived from human amniotic epithelium
EP2294185A2 (en) 2008-05-08 2011-03-16 Coretherapix Slu Multipotent adult stem cell population
CN102333861A (zh) 2008-09-30 2012-01-25 路易斯维尔大学研究基金会有限公司 用于分离非常小的胚胎样(vsel)干细胞的方法
US20110305673A1 (en) 2008-11-12 2011-12-15 The University Of Vermont And State Agriculture College Compositions and methods for tissue repair
ES2675553T3 (es) * 2009-01-13 2018-07-11 StemBios Technologies, Inc. Células madre no embrionarias y usos de las mismas
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
SG173492A1 (en) 2009-02-03 2011-09-29 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising said stem cells.
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
EP2549992B1 (en) 2010-03-23 2019-08-14 The Johns Hopkins University Methods of treatment using stem cell mobilizers
EP2566513A4 (en) 2010-05-07 2014-01-15 Inst Rech S Cliniques De Montreal GFI1B MODULATION AND USES THEREOF
TWI542691B (zh) 2010-08-04 2016-07-21 幹細胞生物科技公司 體幹細胞
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
CN102008650B (zh) 2010-12-16 2017-02-15 天津市医药科学研究所 一种治疗肿瘤的复方中药制剂及其制备方法
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
TWI687519B (zh) 2012-12-06 2020-03-11 美商幹細胞生物科技股份有限公司 Lgr5+體幹細胞
JP2015006184A (ja) 2013-06-24 2015-01-15 ステムバイオス テクノロジーズ, インコーポレイテッドStembios Technologies, Inc. 幹細胞及びそのデータを獲得する方法
CN105687245A (zh) 2014-12-13 2016-06-22 干细胞生物科技公司 制备注射液的方法

Similar Documents

Publication Publication Date Title
JP2012518646A5 (enExample)
MX389346B (es) Formulaciones de anticuerpos monoclonales de alta concentración.
JP2010280671A5 (enExample)
HRP20180237T4 (hr) Metode za liječenje hcv-a
JP2016517888A5 (enExample)
NZ707377A (en) Combination therapy methods for treating proliferative diseases
JP2016034978A5 (enExample)
MY180145A (en) Cenicriviroc compositions and methods of making and using the same
EA201391521A1 (ru) Композиции и способы для ингибирования и/или модулирования эффекторных t-клеток, участвующих в воспалительном нейродегенеративном заболевании
JP2014141525A5 (enExample)
EP2566535A4 (en) DEVICE FOR ADMINISTERING A BIOACTIVE AGENT
RU2015103116A (ru) Новый штамм lactobacillus crispatus
JP2014513722A5 (enExample)
EA201490377A1 (ru) Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата
JP2011225596A5 (enExample)
MX388278B (es) Composiciones y metodos para inhibir masp-1 y/o masp-2 y/ o masp-3 para el tratamiento de la hemoglobinuria paroxistica nocturna
JP2016147915A5 (enExample)
PH12014501620A1 (en) Compositions and methods for the treatment of hepatic diseases and disorders
CO6771406A2 (es) Una composición combinada
JP2013541583A5 (enExample)
JO3508B1 (ar) جهاز طبي محتوي على تركيبة عجينة مشتملة على أريببرازول كمكون فعال وتركيبة عجينة مشتملة على أريببرازول كمكون فعال
JP2016516985A5 (enExample)
RU2018125622A (ru) Способ применения карримицина против резистетности инфекции, спровоцированной микобактерией туберкулеза
EA201592040A1 (ru) Иммуногенная композиция для применения в терапии
RU2015148636A (ru) Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки